In ka badan $9 bilyan oo dawada xiddigta ah ee Qilu ayaa ah wax soo saarkii ugu horreeyay ee gudaha ah ee loo soo sheego wax-soo-saar.

1.In ka badan $9 bilyan oo dawada xiddigta ah ee Qilu ayaa ah wax soo saarkii ugu horreeyay ee gudaha ah ee loo soo sheego wax-soo-saar.Daawooyinka Qilu waxay heshay aqbalaadda CDE ee codsiga liiska ee Aflibercept intraocular intraocular solution oo ay soo gudbisay qaybta cusub ee daawada 3.3, taas oo ah soosaarkii ugu horreeyay ee la soo sheegay ee daawada la midka ah ee Aflibercept ee Shiinaha.

2.Maajo 11, arjiga liiska levosalbuterol hydrochloride atomized inhalation solution oo ay soo gudbisay Hunan Warner Pharmaceutical Co., Ltd. oo leh qaybta daawada guud ee 3 waxaa aqbashay CDE.Levosalbuterol waxaa caadi ahaan loo isticmaalaa 2 agonists receptor.Sida laga soo xigtay xogta Intranet, iibinta terminal l-salbutamol Hydrochloride Aerosol Inhalation Solution ee xarumaha caafimaadka dadweynaha ee Shiinaha sanadka 2021 wuxuu ahaa qiyaastii 200 milyan yuan, iyada oo sanad kasta uu kordhay in ka badan 3209%.

3.Cirbadeynta sodium Enoxaparin waxay keentay ganacsiga shanaad ee la qiimeeyay.Soo dhawaada iibsashada dhexe ayaa ka dhigtay ciyaartoyda ku sugan garoonka heparin nasasho la'aan.Sida laga soo xigtay xogta Intranet, iibinta heparin terminal iyo diyaargarowga heparin ee miisaanka kelli ee hooseeya ee xarumaha caafimaadka dadweynaha ee Shiinaha ayaa dhaaftay 12 bilyan yuan sanadka 2021, iyada oo sanad kasta korodhay 12.98%.Ka mid ah 10-ka badeeco ee ugu sarreeya, cirbadeynta sodium enoxaparin ayaa sii waday inay hoggaamiso, iibka 9 alaabada ayaa si aad ah u kordhay.Mid ka mid ah shanta shirkadood ee isdhexgalka diyaarinta Heparin API, saamiyada Heprui, saamiyada Jianyou iyo dawooyinka Changshan ayaa horseeday dakhliga ganacsiga Heparin ee 2021, sameynta xaalad saddex geesood ah.

4.Xafladda furitaanka dekedda Zhongshan ee soo dejinta daroogada iyo dufcaddii ugu horreysay ee kastamka kastamka soo dejinta daroogada ayaa lagu qabtay dekedda Zhongshan ee Sinotrans Wharf ee Soonka Horumarinta Zhongshan ee Gobolka Guangdong.Dufcaddii ugu horreysay ee "cefotaxime sodium" iyo "Budada Zhupo ee carruurta" oo ay soo dejisay Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. iyo Hong Kong Baohetang Pharmaceutical Co., Ltd. ayaa si guul leh u dhammaystiray nadiifinta kastamka, iyagoo noqday dufcaddii ugu horreysay ee dawooyinka dibadda laga keeno si ay u noqdaan laga sifeeyay dekedda.

5.Maajo 25, aosaikang ayaa mar kale soo gudbisay codsiga suuq-geynta fasalka 2.2 dawooyinka cusub ee dextrolanzoprazole ee duritaanka.Daawada Takeda waxay leedahay diyaarinta afka ee dextrolanzolanzole.Sannadkii 2021, waxay iibisay in ka badan 50.7 bilyan yen (qiyaastii 400 milyan oo doolarka Maraykanka ah) adduunka oo dhan.Waqtigan xaadirka ah, ma jiraan wax soo dejin ama ogolaansho gudaha ah oo la xidhiidha badeecadaha kala duwan ee suuqa gudaha.

6.Maajo 25, Zhejiang Puli Pharmaceutical Co., Ltd. waxay soo gudbisay codsiga kiliinikada fasalka 2.2 ee daawada cusub ee memantine hydrochloride granules.Memantine waa noocyada ugu iibinta badan ee dawooyinka ka hortagga asaasaqa ee daawooyinka habdhiska dareenka.Waqtigan xaadirka ah, waxaa jira kaabsal, kiniiniyo iyo walxaha dareeraha afka laga qaato, mana jiraan granulo loo oggolaaday in lagu taxo ama la soo dejiyo.Puli waa shirkaddii ugu horreysay ee codsata codsiga bukaan-socodka ee granules.

7.Maajo 27keedii, Shandong new era Pharmaceutical Co., Ltd. waxay soo gudbisay arjiga liiska afarta nooc ee kaniiniyada etoxaban toluenesulfonate.Waqtigan xaadirka ah, ma jirto dawada guud ee gudaha suuqa.Hainan Xiansheng Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. iyo Nanjing Hailing Pharmaceutical Group. daroogada ayaa noqonaysa mid aad iyo aad u daran.Edoxaban waa cunsur la xushay Xa inhibitor oo uu sameeyay Sankyo kii ugu horreeyay.Waxaa markii ugu horreysay loo oggolaaday xinjirowga dhiigga ee xididdada dhiigga ee Japan 2011, ka dibna tiro calaamado cusub ah ayaa la ansixiyay.Sannadkii 2021, iibka adduunku wuxuu gaadhay 189.4 bilyan yen (qiyaastii 1.5 bilyan doolarka Maraykanka ah).

JinDun Medicalwaxay leedahay iskaashi cilmi-baaris cilmiyeed oo muddo-dheer ah iyo ku-tallaalidda tignoolajiyada jaamacadaha Shiinaha.Iyada oo Jiangsu kheyraad caafimaad qani ah, waxay leedahay xiriir ganacsi oo muddo dheer India, Koonfur-bari Asia, South Korea, Japan iyo suuqyada kale.Waxa kale oo ay bixisaa adeegyada suuqa iyo iibka ee geeddi-socodka oo dhan laga bilaabo dhexe ilaa API alaabta dhammaatay.Ka faa'ideyso kheyraadka uruursan ee Kiimikada JinDun ee kimistariga fluorine si aad u bixisoadeegyada gaarka ah ee kiimikadala-hawlgalayaasha.Bixi habka hal-abuurka iyo adeegyada cilmi-baarista wasakhaysan si loo beegsado macaamiisha.